搜尋結果
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 18 小時前Shares of the biopharma company surged 30% after the U.S. Food and Drug< ...
Forbes Daily: What’s Left For The Supreme Court This Term?
Forbes· 1 日前Nvidia’s stock saw a rare decline on Thursday, dropping as much as 8% from its morning ...
First, Do No Harm: How Bioethics Can Inform Technology Ethics
The Wall Street Journal· 16 小時前In this role, he delved into some of the questions that can arise at the intersection ... ...
Gilead Stock Gets Boost from HIV Drug Study Results
The Wall Street Journal· 2 日前Shares of Gilead Sciences got a much-needed boost on Thursday after the< ...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 5 日前Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to ...
Constellation is on pace for its best day of the year — here's what may be fueling the rall ...
CNBC· 5 日前Markets rally: The gains on Wall Street picked up steam midafternoon ...
Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds
Forbes· 1 日前Eli Lilly’s weight loss injection tirzepatide — the ingredient inside its wildly popular drugs Mounjaro ...
Here's our first-quarter earnings report card for 32 stocks in the portfolio
CNBC· 1 日前It was another solid quarter for our stocks. Most of the earnings reports — 25 out of 32 ...
The 2024 Patent Landscape And A Roadmap For Future Prosperity
Forbes· 2 日前Today, after examining very recent U.S. executive branch actions that undermine patents, I will ...
National quality agricultural products evaluation station set up in Tai'an
China Daily· 5 日前Institution was held at the Tai'an Institutes for Food and Drug Control on ...